Member Info for one4one

Not @ all Hereforhemo science related posts gets a verification from the investors that has a interest towards HG-CT-1 as opposed to your dribble Hemotruth 🐭

All of the hemogenyx platforms got shut down to make way for the car-t science and at that time cell therapy "2015" was in the infancy but hailed as the medicine of tomorrows world, yes it was exciting & having the privilege of given Access to the science on the London markets ,it has been a educational trip but runners riders have fallen as the science has evolved from Autologous v Allogeneic & Advancing it will time out the custom therapy on the grounds of accessibility affordability Scalability and the critical control point Time with rapid Administration this is where the pharma industry is scrambling to collaborate

Bottom line: understanding the immune system is a better defence than attacking the c/cell....🐭

Not disappointed at all this is where the law of gravity becomes a factual reality yes bring on the eclipse of the "Mint Fiasco"

Bottom line no Fluff : Fear not The Brave this investment has more pips than a pomegranate.... 🐭

No in coming revenue until the warrants are exercised in the meantime the cash burn is smouldering and if you think the Agm following Rns will ignite the Flame then you will be disappointed with a tsunami of shares hitting the market ,But to some the "BOD" will be a relief Safeguarding the awarded share options "21%" from ever becoming a reality the clinical trial is in the early stage and the timeline of efficacy data is a country mile away.....🐭

Hold on i think we are ahead of clinical data here.....🐭

But most of the valuation talk is still ahead of clinical proof...…🐭

Yes the hemogenyx state of the art laboratory was capable of manufacturing the three patients half dose HG-CT-1 and now the trial is escalating to full dosage with 6/10 patients joining cohort phase 1B is where the made tech will cater and hemo will pay per infusion ( cost unknown) the trial has stalled but the cash burn is smouldering.....C’est la vie......🐭

The following Agm Rns i would advise to read and read again "All resolutions passed "standard Practice" operational & clinical updates should not be a reference to phase 1 that is history phase 1B is where the science talks ! ....🐭

CFD is Tax free and this investment has more Pips than a Pomegranate.....🐭

You are correct my bad lets edit: "financial " Dear Sir with reference to a Rns stated equity raised to complete phase 1 would the definition completely lean towards phase 1b :-)))

A dizzy ceo has prolonged the trial on a frugal budget that has not helped, this will be ongoing until financle first aid is applied and that will not happen overnight the next phase of the clinical trial will be dependant on the Efficacy data so expect further placings......🐭

Thankyou for the reply that confirms i still have a Holding @ a higher price which sucks....🐭

Not sure ? what was the name before ? cellbx healthcare ?

Tut....Tut Wrong again Steve E.H.O Qualified Practicing Member CIEHO,sorry i will have to implement a Prohibition Notice as the Cure is about play 🐭

Vivelaplum presently im on assignment @ the IOW music festival will be home tomorrow Do join me for some afternoon Green Tea.....🐭

@STEVE196 you are very Nosey yes i have a invested interest with Hemogenyx and Schott pharmacy-Packaging-preloaded syringes in vein of the next pandemic maybe Hemogenyx will be a customer if CBR gains Parole from the petri-Dish there again Dr Sandler lay claim to Cbr a cure for nuclear poisoning So may-be Not :-)))....🐭

Correction my bad efficacy data from phase 1B.... 🐭

I do not disagree with the concept of your thesis, this is still in the early stages of the clinical trial and the efficacy data from phase 1 is yet to be revealed as i mentioned previously "I think we might be a bit ahead of the clinical data here." Hello " the phase 1b trial has stalled, so politely the speculation/hype is void.

As & when the trial is reinstated with a broader range of patients joining the cohort with a host of different Metabolism that will be when the science talks efficacy presently the science says maybe the market says eventually as witnessed with the fluctuations of the share price, rule of thumb "sell into strength or to say follow the rule of gravity .As there is a few country miles ahead !

@steve196 the mouse all ways Squeeks before the Trap is set.......🐭

I think we might be a bit ahead of the clinical data here. reminder phase 1 was a half dose phase 1B escalating to full dose is where the science talks Efficacy your thesis is bullishly strong but a shadow of weakness as there is no clinical data or proof of concept to support your speculation.

Bottom line no Fluff: I don’t think further speculation is useful until more data is available.....🐭

Well it is a two horse race Autologous v Allogeneic the gamblers are betting on Hemostar after a long spell of being turned out to grass after a injury hemostar has now been fitted with a prospectic leg and will give the punters a good run for their money after collecting millions of placings....🐭